A systematic review of circulating markers in primary chronic venous insufficiency

Phlebology

Volumn 29, Issue 9, 2014, Pages 570-579

  Smith, Ross K ^a   Golledge, Jonathan ^a,b  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

biological markers; blood; plasma; serum; Venous insufficiency

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; HOMOCYSTEINE; TESTOSTERONE; VASCULOTROPIN A;

ADULT; AGED; BLOOD; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; VEIN INSUFFICIENCY;

ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; ESTRADIOL; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; TESTOSTERONE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENOUS INSUFFICIENCY;

EID: 84906857719     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1177/0268355513494375     Document Type: Review

References (37)

1. Ruckley C.Socioeconomic impact of chronic venous insufficiency and leg ulcers.Angiology. 1997;48:67-69.
2. Simka M,Majewski E.The social and economic burden of venous leg ulcers: focus on the role of micronized purified flavonoid fraction adjuvant therapy.Am J Clin Dermatol. 2003;4:573-581.
3. Margolis DJ,Bilker W,Santanna J, et al.Venous leg ulcer: incidence and prevalence in the elderly.Am J Clin Dermatol. 2002;46:381-386.
4. Meissner MH,Gloviczki P,Bergan J, et al.Primary chronic venous disorders.J Vasc Surg. 2007;46:S54-S67.
5. Eberhardt RT,Raffetto JD.Chronic venous insufficiency.Circulation. 2005;111:2398-2409.
6. Abbade LPF,Lastória S.Venous ulcer: epidemiology, physiopathology, diagnosis and treatment.Int J Dermatol. 2005;44:449-456.
7. Pappas PJ,Cerveira JJ,Lal BK, et al.Causes of severe chronic venous insufficiency.Semin Vasc Surg. 2005;18:30-35.
8. Raffetto J,Khalil R.Mechanisms of varicose vein formation: valve dysfunction and wall dilation.Phlebology. 2008;23:85-98.
9. Valencia IC,Falabella A,Kirsner RS, et al.Chronic venous insufficiency and venous leg ulceration.J Am Acad Dermatol. 2001;44:401-421.
10. Golledge J,Quigley F.Pathogenesis of varicose veins.Eur J Vasc Endovasc. 2003;25:319-324.
11. Moore K,Huddleston E,Stacey MC, et al.Venous leg ulcers - the search for a prognostic indicator.Int Wound J. 2007;4:163-172.
12. Moher D,Liberati A,Tetzlaff J, et al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Ann Intern Med. 2009;151:264-269.
13. Eklof B,Rutherford RB,Bergan JJ, et al.Revision of the CEAP classification for chronic venous disorders: Consensus statement.J Vasc Surg. 2004;40:1248-1252.
14. Downs SH,Black N.The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.J Epidemiol Community Health. 1998;52:377-384.
15. Budzyń M,Iskra M,Krasiński Z, et al.Serum iron concentration and plasma oxidant-antioxidant balance in patients with chronic venous insufficency.Med Sci Monit. 2011;17:CR719-CR727.
16. Darvall KAL,Sam RC,Adam DJ, et al.Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls.J Vasc Surg. 2009;49:1235-1241.
17. Durmazlar SP,Akgul A,Eskioglu F.Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: A novel finding with important therapeutic implications.J Dermatolog Treat. 2009;20:336-339.
18. Howlader MH,Coleridge Smith PD.Increased plasma total nitric oxide among patients with severe chronic venous disease.Int Angiol. 2002;21:180-186.
19. Howlader MH,Coleridge Smith PD.Relationship of plasma vascular endothelial growth factor to CEAP clinical stage and symptoms in patients with chronic venous disease.Eur J Vasc Endovasc. 2004;27:89-93.
20. Kendler M,Blendinger C,Haas E.Elevated serum estradiol/testosterone ratio in men with primary varicose veins compared with a healthy control group.Angiology. 2009;60:283-289.
21. Kendler M,Makrantonaki E,Kratzsch J, et al.Elevated sex steroid hormones in great saphenous veins in men.J Vasc Surg. 2010;51:639-646.
22. Lu XW,Chen YJ,Li WM, et al.Venous hypertension induces increased platelet reactivity and accumulation in patients with chronic venous insufficiency.Angiology. 2006;57:321-329.
23. Stvrtinova V,Jahnova E,Weissova S, et al.Inflammatory mechanism involving neutrophils in chronic venous insufficiency of lower limbs.Bratisl Lek Listy. 2001;102:235-239.
24. Takase S,Schmid-Schönbein G,Bergan JJ.Leukocyte activation in patients with venous insufficiency.J Vasc Surg. 1999;30:148-156.
25. Yasim A,Kilinc M,Aral M, et al.Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins.Phlebology. 2008;23:15-20.
26. Zamboni P,Scapoli G,Lanzara V, et al.Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers.Dermatol Surg. 2005;31:644-649.
27. Zhang L,Zhang B,Zhang J, et al.Immune function of erythrocytes in patients with chronic venous insufficiency of the lower extremities.Chin Med J (Engl). 2007;120:2224-2224.
28. Zutt M,Krüger U,Rosenberger A, et al.Increased lipoprotein (a) concentrations in patients with chronic venous leg ulcers: a study on patients with or without postthrombotic syndrome.Wound Repair Regen. 2011;19:168-172.
29. Ciardullo AV,Panico S,Bellati C, et al.High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women.J Vasc Surg. 2000;32:544-549.
30. Jacob MP,Cazaubon M,Scemama A, et al.Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins.Circulation. 2002;106:535-538.
31. Sam RC,Burns PJ,Hobbs SD, et al.The prevalence of hyperhomocysteinemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency.J Vasc Surg. 2003;38:904-908.
32. Dudman N,Temple SE,Guo XW, et al.Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo.Circ Res. 1999;84:409-409.
33. Den Heijer M,Koster T,Blom HJ, et al.Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.N Engl J Med. 1996;334:759-762.
34. Smith PD.Neutrophil activation and mediators of inflammation in chronic venous insufficiency.J Vasc Res. 1999;36:24-36.
35. Smith PC.The causes of skin damage and leg ulceration in chronic venous disease.Int J Low Extrem Wounds. 2006;5:160-168.
36. Smith PDC,Thomas P,Scurr J, et al.Causes of venous ulceration: a new hypothesis.Br Med J (Clin Res Ed). 1988;296:1726-1726.
37. Kistner RL,Eklof B,Masuda EM.Diagnosis of chronic venous disease of the lower extremities: the" CEAP" classification.Mayo Clin Proc. 1996;71:338-345.